pyrophosphate and Phosphorus-Metabolism-Disorders

pyrophosphate has been researched along with Phosphorus-Metabolism-Disorders* in 3 studies

Reviews

1 review(s) available for pyrophosphate and Phosphorus-Metabolism-Disorders

ArticleYear
Metabolic bone disease in children.
    Clinical orthopaedics and related research, 1971, Volume: 77

    Topics: Bone and Bones; Bone Development; Bone Diseases; Calcitonin; Calcium Metabolism Disorders; Child, Preschool; Densitometry; Diphosphates; Homeostasis; Humans; Hyperparathyroidism; Hypophosphatasia; Hypophosphatemia, Familial; Infant; Metabolism, Inborn Errors; Microradiography; Osteogenesis Imperfecta; Osteoporosis; Parathyroid Glands; Parathyroid Hormone; Phosphorus Metabolism Disorders; Pseudohypoparathyroidism; Rickets; Vitamin D

1971

Other Studies

2 other study(ies) available for pyrophosphate and Phosphorus-Metabolism-Disorders

ArticleYear
Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:5

    In calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, metabolic abnormalities favoring extracellular inorganic pyrophosphate (PPi) accumulation have been suspected. Elevations of intracellular PPi in cultured skin fibroblasts from a single French kindred with familial CPPD deposition (19) and elevated nucleoside triphosphate pyrophosphohydrolase activity (NTPPPH), which generates PPi in extracts of CPPD crystal-containing cartilages (14) favor this suspicion. To determine whether NTPPPH activity or PPi content of cells might be a disease marker expressed in extraarticular cells, human skin-derived fibroblasts were obtained from control donors and patients affected with the sporadic and familial varieties of CPPD (CPPD-S and CPPD-F) deposition. Intracellular PPi was elevated in both CPPD-S (P less than 0.05) and CPPD-F (P less than 0.01) fibroblasts compared with control fibroblasts. Ecto-NTPPPH activity was elevated in CPPD-S (P less than 0.01) but not CPPD-F. Intracellular PPi correlated with ecto-NTPPPH (P less than 0.01). Elevated PPi levels in skin fibroblasts may serve as a biochemical marker for patients with familial or sporadic CPPD crystal deposition disease; ecto-NTPPPH activity further separates the sporadic and familial disease types. Expression of these biochemical abnormalities in nonarticular cells implies a generalized metabolic abnormality.

    Topics: Calcium Pyrophosphate; Cells, Cultured; Crystallization; Diphosphates; Fibroblasts; Humans; Phosphorus Metabolism Disorders; Pyrophosphatases; Skin

1986
[Skeletal x-ray studies in tubular bone pathology in children].
    Voprosy okhrany materinstva i detstva, 1980, Volume: 25, Issue:5

    Topics: Absorptiometry, Photon; Acidosis, Renal Tubular; Adolescent; Bone and Bones; Bone Diseases; Child; Child, Preschool; Diphosphates; Fanconi Syndrome; Humans; Kidney Diseases; Osteomalacia; Phosphorus Metabolism Disorders; Radionuclide Imaging; Renal Tubular Transport, Inborn Errors; Technetium

1980